Fetal Growth and Development

Fetal Macrosomía, 2016

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2015

2014

How to Use the Protocols and Guidelines The primary aim of the Obstetrics & Gynaecology Protocols and Guidelines is to improve the health of our women and their newborns by standardizing the clinical care they receive at the University Teaching Hospital (UTH). The development of these protocols and guidelines was the product of numerous hours dedicated by many people from the Department of Obstetrics and Gynaecology at UTH, the Medical Education Partnership Initiative (MEPI) at University of Zambia (UNZA), and the Centre for Infectious Disease Research in Zambia (CIDRZ)/University of North Carolina at Chapel Hill (UNC). We expect no different for implementation of the same to be a success: many people will need to be involved. The purpose of the protocols and guidelines is not to replace specialty textbooks or medical journals. They emphasize those clinical practices that are evidence-based and available in Zambia. Pocket-sized, this booklet is best used at the bedside, on hospital rounds, and in admission. We acknowledge that patients are individuals and do not always fit into premade boxes. When a doctor chooses to stray from the guidance provided in these pages, he/she should document the deviation and reason thereof in the woman's medical file. Topics are divided into four sections: early pregnancy complications, labour ward, medical conditions in pregnancy, and gynaecology & general medical conditions. With regard to format, we hope the protocols and guidelines are self-explanatory. Each topic is divided into sections:

Sultan Qaboos University Medical Journal, 2016

This study aimed to determine causes of maternal and neonatal morbidity and mortality at Nizwa Hospital, Nizwa, Oman, in order to improve the quality of healthcare. Methods: A prospective self-audit was conducted by the Maternal Morbidity Working Group to critically analyse secondary healthcare lapses during the management of all obstetric cases at Nizwa Hospital in order to highlight possible strategies to avoid such errors in future. Results: Major obstetric morbidity occurred in 3.97% of cases. Leading causes of death were obstetric haemorrhages caused by placenta accreta and rupture of the uterus, followed by eclampsia, vaginal tears and wound haematomas. Sickle cell disease and H1N1 influenza type A-associated pneumonia were the main indirect causes of maternal mortality. In some cases, uncontrolled diabetes led to birth asphyxia, stillbirths and an increased rate of congenital anomalies. Conclusion: Auditing morbidity and mortality can help in recognising, anticipating and managing risks to maternal and neonatal health.

BMJ, 2003

2005

A review of publications relating to significant advances in the specialty of Obstetrics and Gynaecology over the past four years will be discussed: topics reviewed will have an important impact on reducing maternal/fetal morbidity and mortality and should improve on woman's health care.

Obs and Gyn Newborn Care 1, 2022

This subcourse is approved for resident and correspondence course instruction. It reflects the current thought of the Academy of Health Sciences and conforms to printed Department of the Army doctrine as closely as currently possible. Development and progress render such doctrine continuously subject to change.

American Journal of Obstetrics and Gynecology, 2004

Objective: The purpose of this study was to describe current practice patterns for 7 controversial topics in Maternal-Fetal Medicine. Study design: An interactive survey of obstetric treatment was performed as part of a postgraduate course at the 2004 Annual Meeting of the Society for Maternal-Fetal Medicine. Seven controversial topics were addressed, which included tocolytic therapy, progesterone supplementation for the prevention of preterm birth, screening for inherited thrombophilia, cervical cerclage for a shortened cervix, treatment of preterm premature rupture of membranes, magnesium sulfate seizure prophylaxis, and dexamethasone therapy for HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome.

This guideline is intended as a guide and provided for information purposes only. The information has been prepared using a multidisciplinary approach with reference to the best information and evidence available at the time of preparation. No assurance is given that the information is entirely complete, current, or accurate in every respect. The guideline is not a substitute for clinical judgement, knowledge and expertise, or medical advice. Variation from the guideline, taking into account individual circumstances, may be appropriate. This guideline does not address all elements of standard practice and accepts that individual clinicians are responsible for: • Providing care within the context of locally available resources, expertise, and scope of practice • Supporting consumer rights and informed decision making, including the right to decline intervention or ongoing management • Advising consumers of their choices in an environment that is culturally appropriate and which enables comfortable and confidential discussion. This includes the use of interpreter services where necessary • Ensuring informed consent is obtained prior to delivering care • Meeting all legislative requirements and professional standards • Applying standard precautions, and additional precautions as necessary, when delivering care • Documenting all care in accordance with mandatory and local requirements Queensland Health disclaims, to the maximum extent permitted by law, all responsibility and all liability (including without limitation, liability in negligence) for all expenses, losses, damages and costs incurred for any reason associated with the use of this guideline, including the materials within or referred to throughout this document being in any way inaccurate, out of context, incomplete or unavailable.